Intralesional recombinant alpha 2a interferon therapy in superficial transitional cell carcinoma of the bladder.
Di Stasi
S M
SM
Tabilio
A
A
Virgili
G
G
Vespasiani
G
G
Porena
M
M
Micali
F
F
D000368:Aged; D000369:Aged, 80 and over; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins